ISL1 was involved in triple-negative breast cancer, melanoma, and gastric cancer progression [11–13], and it was highly expressed in non-Hodgkin lymphoma compared to normal lymph nodes or Hodgkin lymphoma [14]. Here, ISL1 is linked to gastric cancer.